Cargando…
Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP–Glaucoma
PURPOSE: To determine if one injection of a sustained release formulation of dorzolamide in biodegradable microparticles (DPP) reduces retinal ganglion cell (RGC) loss in a rat model of glaucoma. METHODS: We injected either DPP or control microparticles intravitreally in rats. Two days later, unilat...
Autores principales: | Pitha, Ian, Kimball, Elizabeth C., Oglesby, Ericka N., Pease, Mary Ellen, Fu, Jie, Schaub, Julie, Kim, Yoo-Chun, Hu, Qi, Hanes, Justin, Quigley, Harry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879766/ https://www.ncbi.nlm.nih.gov/pubmed/29616152 http://dx.doi.org/10.1167/tvst.7.2.13 |
Ejemplares similares
-
Regional Retinal Ganglion Cell Axon Loss in a Murine Glaucoma Model
por: Schaub, Julie A., et al.
Publicado: (2017) -
Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
por: Pitha, Ian, et al.
Publicado: (2018) -
Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma
por: Quigley, Harry A., et al.
Publicado: (2015) -
Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant Culture
por: Johnson, Thomas V., et al.
Publicado: (2016) -
Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model
por: Steinhart, Matthew R., et al.
Publicado: (2012)